Track Record
Divestment of Late Life Cycle Products

A large multinational pharmaceutical company decided to more diligently manage the late life cycle products in its portfolio, and to divest such products at a point when sales had begun to decline and sales resources had been reassigned to other products. In return, the company would generate cash that could be used to invest in its new product launches.

This company had come to know Plexus Ventures during an earlier transaction when the company had out-licensed a product to a client of Plexus Ventures. The company asked Plexus Ventures to manage a divestment project for them. Plexus Ventures prepared the Information Memorandums, identified appropriate targets, generated competition for the asset, assisted with buyers’ due diligence investigation, and assisted with negotiation of the definitive agreements.

As a result of the controlled auction process utilized by Plexus Ventures, the multinational received a greater than expected return for the asset. They have since retained Plexus Ventures to manage additional divestment assignments.

 

Back to In-Licensing Review our Divestments services